UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 803

Sortiert nach

Breast cancer brain metastases: biology and new clinical perspectives

Breast cancer research : BCR, 2016-01, Vol.18 (1), p.8, Article 8

2016

Volltextzugriff (PDF)

Tucatinib, Trastuzumab, and Capecitabine for HER2-Positive Metastatic Breast Cancer

The New England journal of medicine, 2020-02, Vol.382 (7), p.597-609

2020

Volltextzugriff (PDF)

Accession of Tumor Heterogeneity by Multiplex Transcriptome Profiling of Single Circulating Tumor Cells

Clinical chemistry (Baltimore, Md.), 2016-11, Vol.62 (11), p.1504-1515

2016

Volltextzugriff (PDF)

Specific microRNA signatures in exosomes of triple-negative and HER2-positive breast cancer patients undergoing neoadjuvant therapy within the GeparSixto trial

BMC medicine, 2018-10, Vol.16 (1), p.179-179, Article 179

2018

Volltextzugriff (PDF)

Diagnostic potential of PTEN-targeting miR-214 in the blood of breast cancer patients

Breast cancer research and treatment, 2012-08, Vol.134 (3), p.933-941

2012

Volltextzugriff (PDF)

Interplay of lncRNA H19/miR‐675 and lncRNA NEAT1/miR‐204 in breast cancer

Molecular oncology, 2019-05, Vol.13 (5), p.1137-1149

2019

Volltextzugriff (PDF)

Detection of Circulating Tumor Cells in Peripheral Blood of Patients with Metastatic Breast Cancer: A Validation Study of the CellSearch System

Clinical cancer research, 2007-02, Vol.13 (3), p.920-928

2007

Volltextzugriff (PDF)

Prognostic Impact of Circulating Tumor Cells for Breast Cancer Patients Treated in the Neoadjuvant "Geparquattro" Trial

Clinical cancer research, 2017-09, Vol.23 (18), p.5384-5393

2017

Volltextzugriff (PDF)

Pathologic Complete Response After Neoadjuvant Chemotherapy Plus Trastuzumab Predicts Favorable Survival in Human Epidermal Growth Factor Receptor 2–Overexpressing Breast Cancer: Results From the TECHNO Trial of the AGO and GBG Study Groups

Journal of clinical oncology, 2011-09, Vol.29 (25), p.3351-3357

2011

Volltextzugriff (PDF)

Exosomal microRNAs as tumor markers in epithelial ovarian cancer

Molecular oncology, 2018-11, Vol.12 (11), p.1935-1948

2018

Volltextzugriff (PDF)

Increased serum levels of circulating exosomal microRNA-373 in receptor-negative breast cancer patients

Oncotarget, 2014-10, Vol.5 (20), p.9650-9663

2014

Volltextzugriff (PDF)

Prognosis of Women With Primary Breast Cancer Diagnosed During Pregnancy: Results From an International Collaborative Study

Journal of clinical oncology, 2013-07, Vol.31 (20), p.2532-2539

2013

Volltextzugriff (PDF)

Changes in Keratin Expression during Metastatic Progression of Breast Cancer: Impact on the Detection of Circulating Tumor Cells

Clinical cancer research, 2012-02, Vol.18 (4), p.993-1003

2012

Volltextzugriff (PDF)

Myocardial injury detected by T1 and T2 mapping on CMR predicts subsequent cancer therapy–related cardiac dysfunction in patients with breast cancer treated by epirubicin-based chemotherapy or left-sided RT

European radiology, 2022-03, Vol.32 (3), p.1853-1865

2022

Volltextzugriff (PDF)

Changes in serum levels of miR-21, miR-210, and miR-373 in HER2-positive breast cancer patients undergoing neoadjuvant therapy: a translational research project within the Geparquinto trial

Breast cancer research and treatment, 2014-08, Vol.147 (1), p.61-68

2014

Volltextzugriff (PDF)

Heterogeneity of estrogen receptor expression in circulating tumor cells from metastatic breast cancer patients

PloS one, 2013-09, Vol.8 (9), p.e75038

2013

Volltextzugriff (PDF)

Circulating Tumor Cells in Breast Cancer: Correlation to Bone Marrow Micrometastases, Heterogeneous Response to Systemic Therapy and Low Proliferative Activity

Clinical cancer research, 2005-05, Vol.11 (10), p.3678-3685

2005

Volltextzugriff (PDF)

Perceived relatedness, death acceptance, and demoralization in patients with cancer

Supportive care in cancer, 2020-06, Vol.28 (6), p.2693-2700

2020

Volltextzugriff (PDF)

Comparison of the HER2, estrogen and progesterone receptor expression profile of primary tumor, metastases and circulating tumor cells in metastatic breast cancer patients

BMC cancer, 2016-07, Vol.16 (1), p.522-522, Article 522

2016

Volltextzugriff (PDF)

Diagnostic and prognostic potential of serum miR-7, miR-16, miR-25, miR-93, miR-182, miR-376a and miR-429 in ovarian cancer patients

British journal of cancer, 2015-11, Vol.113 (9), p.1358-1366

2015

Volltextzugriff (PDF)

Detection and HER2 Expression of Circulating Tumor Cells: Prospective Monitoring in Breast Cancer Patients Treated in the Neoadjuvant GeparQuattro Trial

Clinical cancer research, 2010-05, Vol.16 (9), p.2634-2645

2010

Volltextzugriff (PDF)

Detection and Isolation of Circulating Tumor Cells from Breast Cancer Patients Using CUB Domain-Containing Protein 1

Journal of proteome research, 2023-04, Vol.22 (4), p.1213-1230

2023

Volltextzugriff (PDF)

A New Molecular Predictor of Distant Recurrence in ER-Positive, HER2-Negative Breast Cancer Adds Independent Information to Conventional Clinical Risk Factors

Clinical cancer research, 2011-09, Vol.17 (18), p.6012-6020

2011

Volltextzugriff (PDF)

Detection and characterization of putative metastatic precursor cells in cancer patients

Clinical chemistry (Baltimore, Md.), 2007-03, Vol.53 (3), p.537-539

2007

Volltextzugriff (PDF)

1 – 25 von 803

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(683)
Mit Volltextzugriff
(775)

Publikationsform

Sprache

Englisch
(681)
Deutsch
(157)
Japanisch
(71)
Russisch
(2)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

Menü

Weitere Dienste

Einstellungen

Breast cancer brain metastases: biology and new clinical perspectives

Tucatinib, Trastuzumab, and Capecitabine for HER2-Positive Metastatic Breast Cancer

Accession of Tumor Heterogeneity by Multiplex Transcriptome Profiling of Single Circulating Tumor Cells

Specific microRNA signatures in exosomes of triple-negative and HER2-positive breast cancer patients undergoing neoadjuvant therapy within the GeparSixto trial

Diagnostic potential of PTEN-targeting miR-214 in the blood of breast cancer patients

Interplay of lncRNA H19/miR‐675 and lncRNA NEAT1/miR‐204 in breast cancer

Detection of Circulating Tumor Cells in Peripheral Blood of Patients with Metastatic Breast Cancer: A Validation Study of the CellSearch System

Prognostic Impact of Circulating Tumor Cells for Breast Cancer Patients Treated in the Neoadjuvant "Geparquattro" Trial

Pathologic Complete Response After Neoadjuvant Chemotherapy Plus Trastuzumab Predicts Favorable Survival in Human Epidermal Growth Factor Receptor 2–Overexpressing Breast Cancer: Results From the TECHNO Trial of the AGO and GBG Study Groups

Exosomal microRNAs as tumor markers in epithelial ovarian cancer

Increased serum levels of circulating exosomal microRNA-373 in receptor-negative breast cancer patients

Prognosis of Women With Primary Breast Cancer Diagnosed During Pregnancy: Results From an International Collaborative Study

Changes in Keratin Expression during Metastatic Progression of Breast Cancer: Impact on the Detection of Circulating Tumor Cells

Myocardial injury detected by T1 and T2 mapping on CMR predicts subsequent cancer therapy–related cardiac dysfunction in patients with breast cancer treated by epirubicin-based chemotherapy or left-sided RT

Changes in serum levels of miR-21, miR-210, and miR-373 in HER2-positive breast cancer patients undergoing neoadjuvant therapy: a translational research project within the Geparquinto trial

Heterogeneity of estrogen receptor expression in circulating tumor cells from metastatic breast cancer patients

Treatment of breast cancer during pregnancy: an observational study

Circulating Tumor Cells in Breast Cancer: Correlation to Bone Marrow Micrometastases, Heterogeneous Response to Systemic Therapy and Low Proliferative Activity

Perceived relatedness, death acceptance, and demoralization in patients with cancer

Comparison of the HER2, estrogen and progesterone receptor expression profile of primary tumor, metastases and circulating tumor cells in metastatic breast cancer patients

Diagnostic and prognostic potential of serum miR-7, miR-16, miR-25, miR-93, miR-182, miR-376a and miR-429 in ovarian cancer patients

Detection and HER2 Expression of Circulating Tumor Cells: Prospective Monitoring in Breast Cancer Patients Treated in the Neoadjuvant GeparQuattro Trial

Detection and Isolation of Circulating Tumor Cells from Breast Cancer Patients Using CUB Domain-Containing Protein 1

A New Molecular Predictor of Distant Recurrence in ER-Positive, HER2-Negative Breast Cancer Adds Independent Information to Conventional Clinical Risk Factors

Detection and characterization of putative metastatic precursor cells in cancer patients

Suchergebnisse filtern